16 September 2021 - The pharmaceutical industry, bizarrely, told the American people this week that allowing Medicare to negotiate drug prices is tantamount to socialism, rather than an example of a healthy, competitive marketplace.
The industry said in an open letter to Congress that letting Medicare haggle on behalf of its 63 million beneficiaries would give the government “the power to set the price of medicines.”